Status:
COMPLETED
Nebulized Hypertonic Saline for Bronchiolitis
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
UCSF Benioff Children's Hospital Oakland
Thrasher Research Fund
Conditions:
Bronchiolitis
Eligibility:
All Genders
Up to 24 years
Phase:
PHASE2
PHASE3
Brief Summary
This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital a...
Detailed Description
Bronchiolitis is the most common viral respiratory infection in young children and infants. It is responsible for hundreds of thousands of outpatient visits and hospitalizations every year. Hypertonic...
Eligibility Criteria
Inclusion
- clinical diagnosis of viral bronchiolitis
- between November and April
Exclusion
- prematurity \< 34 weeks
- chronic lung disease
- congenital heart disease
- history of wheezing, asthma or albuterol use
- tracheostomy status
- need for intensive care of assisted ventilation
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
447 Patients enrolled
Trial Details
Trial ID
NCT00619918
Start Date
February 1 2008
End Date
May 1 2011
Last Update
November 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital Los Angeles
Los Angeles, California, United States, 90027
2
Children's Hospital & Research Center at Oakland
Oakland, California, United States, 94609